Artelo Biosciences (ARTL) Prepaid Assets (2017 - 2025)
Artelo Biosciences (ARTL) posted quarterly Prepaid Assets of $95000.0 for Q4 2025, down 56.62% year-over-year from $219000.0 in Q4 2024, and down 11.21% quarter-over-quarter from $107000.0 in Q3 2025.
Artelo Biosciences (ARTL) Prepaid Assets (2017 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Prepaid Assets for 9 consecutive years, with $95000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets fell 56.62% year-over-year to $95000.0; the TTM figure through Dec 2025 stood at $95000.0 (down 56.62% YoY), while the FY2025 annual figure was $95000.0, down 56.62% from the prior year.
- Prepaid Assets fell to $95000.0 in Q4 2025 per ARTL's latest filing, from $107000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.1 million in Q1 2022 and bottomed at $3000.0 in Q4 2021.
- Historically, Prepaid Assets has averaged $435110.4 across 5 years, with a median of $403000.0 in 2021.
- On a YoY basis, Prepaid Assets climbed as much as 135.04% in 2021 and fell as far as 97.3% in 2021.
- Artelo Biosciences' Prepaid Assets stood at $3000.0 in 2021, then soared by 26200.0% to $789000.0 in 2022, then dropped by 29.78% to $554000.0 in 2023, then tumbled by 60.47% to $219000.0 in 2024, then slumped by 56.62% to $95000.0 in 2025.
- Business Quant data shows ARTL's Prepaid Assets at $95000.0 in Q4 2025, $107000.0 in Q3 2025, and $167000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 95,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 167,000.00 |
| Mar 31, 2025 | 212,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 566,000.00 |
| Mar 31, 2024 | 579,000.00 |
| Dec 31, 2023 | 554,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 611,000.00 |
| Mar 31, 2023 | 903,000.00 |
| Dec 31, 2022 | 789,000.00 |
| Sep 30, 2022 | 686,000.00 |
| Jun 30, 2022 | 826,000.00 |
| Mar 31, 2022 | 1.08 Mn |
| Nov 30, 2021 | 3,000.00 |
| Aug 31, 2021 | 252,000.00 |
| May 31, 2021 | 175,472.00 |
| Feb 28, 2021 | 186,735.00 |